SEC Tracker
Get the app

TRex Bio TRXB

TRex Bio reports new shareholder

Ownership stake disclosure by Johnson & Johnson Innovation - JJDC, Inc.

Form
Schedule 13G
Filed
Importance
Routine
  1. Johnson & Johnson filed a Schedule 13G on Oct 15, 2026
  2. JJDC and J&J are the reporting persons
  3. Ownership percentage based on 27,577,535 shares
  4. Schedule 13G covers common stock with CUSIP 89531N100

Written from the Schedule 13G on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when TRex Bio files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Same SIC code (2836) and public float not reported.

  1. Adaptimmune Therapeutics ADAP
  2. Adverum Biotechnologies ADVM
  3. AgomAb Therapeutics AGMB
  4. Alvotech ALVO
  5. Argenx ARGX